It isn’t a bad idea to follow billionaires’ investment strategies. While one must not blindly do what they do, keeping an eye ...

Global Payments has seen quite an underwhelming performance in the last year and YTD. Click here to find out what leads me to ...

The company’s projected adjusted diluted EPS for 2025 is between $5.05 and $5.25, marking double-digit growth at the midpoint. Abbott’s first-quarter 2025 adjusted EPS is expected to be between $1.05 ...

The business has successfully expanded its share in a highly fragmented market from 4% in 2007 to 11% in 2024 in the US through a combination of its “cluster” strategy and bolt-on acquisitions.

Johnson & Johnson's Q4 2024 earnings missed EPS expectations, but broadly met revenue targets. Click here to read why JNJ ...

Investors faced a unique dynamic in 2024, with a range of catalysts dominating the mind share of most investors. From surging ...

Textron (NYSE:TXT), a multifaceted industrial company known for its aviation and defense businesses, released its ...

Procter & Gamble (NYSE:PG) (P&G) reported its financial results for the second quarter of fiscal year 2024, surpassing ...

Procter & Gamble is trading near the top of the Dow Wednesday after the consumer staples giant beat expectations for its ...

Rigetti Computing (RGTI) saw its shares surge in the last session with trading volume being higher than average. The latest ...

GE Vernova missed analyst expectations on fourth-quarter EPS and revenue, but it maintained its guidance for the coming year.

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.